SpaceX首次警告投资者：马斯克或重返政治，4000亿美元估值面临不确定性！

Core Insights - SpaceX has introduced a political risk warning in its investment documents, indicating that Elon Musk may re-engage in political activities, which could distract him from his role as CEO [1][3] - The timing of this warning is significant as it follows Musk's recent departure from a government role and his establishment of a new political organization, suggesting ongoing political ambitions [3] - SpaceX's valuation has risen to approximately $400 billion, up from $350 billion last December, driven by its leading position in the commercial space sector and the rapid growth of its Starlink satellite internet business [4] Political Risk Warning - This is the first time SpaceX has included a clause regarding Musk's potential political involvement in its formal investment documents [3] - The warning highlights that Musk's possible return to a government role could impact his focus on daily management of the company [3] - Musk's political activities may have direct implications for SpaceX's government contracts, given its status as a key contractor for NASA and the military [3] Valuation and Business Performance - The company plans to repurchase up to $1.25 billion in shares at a price of $212 per share, significantly higher than the previous trading price of $185 [4] - SpaceX's revenue is projected to reach $15.5 billion this year, with the Starlink business contributing around $8 billion, accounting for approximately 60% of total revenue [4] - The company completed a record 134 launch missions last year, reinforcing its dominant position in the rocket launch market [4] Technological Innovation - Despite political uncertainties, SpaceX continues to demonstrate strong momentum in technological innovation [4] - The Starship project, although facing testing setbacks, is noted for its revolutionary reusable design, which is reshaping the aerospace industry [4] - SpaceX's successful collaboration with government agencies remains intact, with most federal contracts deemed strategically important despite previous scrutiny during the Trump administration [4]